Therapeutic strategies of melatonin in cancer patients: a systematic review and meta-analysis

References

• TuliHSKashyapDSharmaAKSandhuSSMolecular aspects of melatonin (MLT)-mediated therapeutic effectsLife Sci201513514715726135621
   PubMed Web of Science ®Google Scholar
• SuSCHsiehMJYangWEChungWHReiterRJYangSFCancer metastasis: Mechanisms of inhibition by melatoninJ Pineal Res2017621e12370
   Web of Science ®Google Scholar
• InnominatoPFLimASPaleshOThe effect of melatonin on sleep and quality of life in patients with advanced breast cancerSupport Care Cancer20162431097110526260726
   PubMed Web of Science ®Google Scholar
• Acuña-CastroviejoDRahimIAcuña-FernándezCMelatonin, clock genes and mitochondria in sepsisCell Mol Life Sci201774213965398728785808
   PubMed Web of Science ®Google Scholar
• SchernhammerESHankinsonSEUrinary melatonin levels and breast cancer riskJ Natl Cancer Inst200597141084108716030307
   PubMedGoogle Scholar
• KarasekMKowalskiAJSuzinJZylinskaKSwietoslawskiJSerum melatonin circadian profiles in women suffering from cervical cancerJ Pineal Res2005391737615978060
   PubMed Web of Science ®Google Scholar
• ZhaoMWanJZengKThe Reduction in Circulating Melatonin Level May Contribute to the Pathogenesis of Ovarian Cancer: A Retrospective StudyJ Cancer20167783183627162542
   PubMed Web of Science ®Google Scholar
• TurgutMUyanikgilYBakaMPinealectomy exaggerates and melatonin treatment suppresses neuroma formation of transected sciatic nerve in rats: gross morphological, histological and stereological analysisJ Pineal Res200538428429115813906
   PubMed Web of Science ®Google Scholar
• BartschHBuchbergerAFranzHEffect of melatonin and pineal extracts on human ovarian and mammary tumor cells in a chemosensitivity assayLife Sci200067242953296011133007
   PubMed Web of Science ®Google Scholar
• ReiterRJRosales-CorralSATanDXMelatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and MetastasisInt J Mol Sci2017184E84328420185
   PubMed Web of Science ®Google Scholar
• AsghariMHMoloudizargariMGhobadiEFallahMAbdollahiMMelatonin as a multifunctional anti-cancer molecule: Implications in gastric cancerLife Sci2017185384528739305
   PubMed Web of Science ®Google Scholar
• González-GonzálezAMediavillaMDSánchez-BarcelóEJMelatonin: A Molecule for Reducing Breast Cancer RiskMolecules2018232E33629415446
   PubMed Web of Science ®Google Scholar
• GonzálezAGonzález-GonzálezAAlonso-GonzálezCMenéndez-MenéndezJMartínez-CampaCCosSMelatonin inhibits angiogenesis in SH-SY5Y human neuroblastoma cells by downregulation of VEGFOncol Rep20173742433244028259965
   PubMed Web of Science ®Google Scholar
• ZontaYRMartinezMCamargoICMelatonin Reduces Angiogenesis in Serous Papillary Ovarian Carcinoma of Ethanol-Preferring RatsInt J Mol Sci2017184E76328398226
   PubMed Web of Science ®Google Scholar
• GonzálezAAlvarez-GarcíaVMartínez-CampaCIn vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatoninCurr Cancer Drug Targets201010327928620370689
   PubMed Web of Science ®Google Scholar
• PlaimeePKhamphioMWeerapreeyakulNBarusruxSJohnsNPImmunomodulatory effect of melatonin in SK-LU-1 human lung adenocarcinoma cells co-cultured with peripheral blood mononuclear cellsCell Prolif201447540641525053373
   PubMed Web of Science ®Google Scholar
• KimTHChoSGMelatonin-induced KiSS1 expression inhibits triple-negative breast cancer cell invasivenessOncol Lett20171422511251628781689
   PubMed Web of Science ®Google Scholar
• AkbarzadehMMovassaghpourAAGhanbariHThe potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cellsSci Rep2017711706229213108
   PubMed Web of Science ®Google Scholar
• SainzRMMayoJCTanDXLeónJManchesterLReiterRJMelatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanismProstate2005631294315378522
   PubMed Web of Science ®Google Scholar
• SuwanjangWAbramovAYCharngkaewKGovitrapongPChetsawangBMelatonin prevents cytosolic calcium overload, mitochondrial damage and cell death due to toxically high doses of dexamethasone-induced oxidative stress in human neuroblastoma SH-SY5Y cellsNeurochem Int201697344127155536
   PubMed Web of Science ®Google Scholar
• Sanchez-BarceloEJMediavillaMDAlonso-GonzalezCReiterRJMelatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiationExpert Opin Investig Drugs2012216819831
   PubMed Web of Science ®Google Scholar
• AsghariMHGhobadiEMoloudizargariMFallahMAbdollahiMDoes the use of melatonin overcome drug resistance in cancer chemotherapy?Life Sci201819614315529374563
   PubMed Web of Science ®Google Scholar
• WangTLiuBGuanYMelatonin inhibits the proliferation of breast cancer cells induced by bisphenol A via targeting estrogen receptor-related pathwaysThorac Cancer20189336837529330934
   PubMed Web of Science ®Google Scholar
• ProiettiSCatizoneAMasielloMGIncrease in motility and invasiveness of MCF7 cancer cells induced by nicotine is abolished by melatonin through inhibition of ERK phosphorylationJ Pineal Res2018644e1246729338098
   PubMed Web of Science ®Google Scholar
• ChuffaLGAReiterRJLupiLAMelatonin as a promising agent to treat ovarian cancer: molecular mechanismsCarcinogenesis2017381094595228575150
   PubMed Web of Science ®Google Scholar
• WangYMJinBZAiFThe efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trialsCancer Chemother Pharmacol20126951213122022271210
   PubMed Web of Science ®Google Scholar
• SeelyDWuPFritzHMelatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trialsIntegr Cancer Ther201211429330322019490
   PubMed Web of Science ®Google Scholar
• SookprasertAJohnsNPPhunmaneeAMelatonin in patients with cancer receiving chemotherapy: a randomized, double-blind, placebo-controlled trialAnticancer Res201434127327733725503168
   PubMed Web of Science ®Google Scholar
• HarrisJDQuatmanCEManringMMSistonRAFlaniganDCHow to write a systematic reviewAm J Sports Med201442112761276823925575
   PubMed Web of Science ®Google Scholar
• JadadARMooreRACarrollDAssessing the quality of reports of randomized clinical trials: is blinding necessary?Control Clin Trials19961711128721797
   PubMedGoogle Scholar
• KubatkaPZuborPBusselbergDMelatonin and breast cancer: Evidences from preclinical and human studiesCrit Rev Oncol Hematol201812213314329458781
   PubMed Web of Science ®Google Scholar
• YasuedaAUrushimaHItoTEfficacy and Interaction of Antioxidant Supplements as Adjuvant Therapy in Cancer Treatment: A Systematic ReviewIntegr Cancer Ther2016151173926503419
   PubMed Web of Science ®Google Scholar
• SaeidniaSAbdollahiMAntioxidants: friends or foe in prevention or treatment of cancer: the debate of the centuryToxicol Appl Pharmacol20132711496323680455
   PubMed Web of Science ®Google Scholar
• LissoniPBarniSArdizzoiaARandomized study with the pineal hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant to a first-line chemotherapy containing cisplatinOncology19924953363391382256
   PubMed Web of Science ®Google Scholar
• LissoniPBrivioFFumagalliLNeuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumorsAnticancer Res2008282B1377138118505083
   PubMed Web of Science ®Google Scholar
• LissoniPBiochemotherapy with immunomodulating pineal hormones other than melatonin: 5-methoxytryptamine as a new oncostatic pineal agentPathol Biol (Paris)2007553–419820017451889
   PubMedGoogle Scholar
• LissoniPBiochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasmsPathol Biol2007553–420120417446010
   PubMedGoogle Scholar
• LissoniPChilelliMVillaSCerizzaLTanciniGFive years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trialJ Pineal Res2003351121512823608
   PubMed Web of Science ®Google Scholar
• CereaGVaghiMArdizzoiaABiomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinationsAnticancer Res2003232C1951195412820485
   PubMed Web of Science ®Google Scholar
• LissoniPIs there a role for melatonin in supportive care?Support Care Cancer200210211011611862501
   PubMed Web of Science ®Google Scholar
• YanJJSongFWangKWuMCCo-antitumor effect and hepatic protection of melatonin on advanced primary liver cancer treated by transcatheter arterial chemoembolizationAcad J Sec Mil Med Univ2001229858861
   Google Scholar
• LissoniPMandalàMBrivioFAbrogation of the negative influence of opioids on IL-2 immunotherapy of renal cell cancer by melatoninEur Urol200038111511810859453
   PubMed Web of Science ®Google Scholar
• LissoniPBarniSMandalàMDecreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical statusEur J Cancer199935121688169210674014
   PubMed Web of Science ®Google Scholar
• LissoniPTanciniGBarniSTreatment of cancer chemotherapy-induced toxicity with the pineal hormone melatoninSupport Care Cancer1997521261299069612
   PubMed Web of Science ®Google Scholar
• LissoniPPaolorossiFArdizzoiaAA randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical stateJ Pineal Res199723115199379341
   PubMed Web of Science ®Google Scholar
• YanJJSongFWuMCPineal hormone melatonin for treating patients with unresectable advanced hepatocellular cancerTUMOR (Shanghai)1997176452454
   Google Scholar
• LissoniPMeregalliSNosettoLIncreased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy aloneOncology199653143468570130
   PubMed Web of Science ®Google Scholar
• LissoniPBrivioOBrivioFAdjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanomaJ Pineal Res19962142392428989723
   PubMed Web of Science ®Google Scholar
• LissoniPArdizzoiaABarniSA randomized study of tamoxifen alone versus tamoxifen plus melatonin in estrogen receptor-negative heavily pretreated metastatic breast-cancer patientsOncol Rep19952587187321597833
   PubMed Web of Science ®Google Scholar
• LissoniPBarniSTanciniGA randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanomaBr J Cancer19946911961998286206
   PubMed Web of Science ®Google Scholar
• LissoniPBarniSArdizzoiaATanciniGContiAMaestroniGA randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasmsCancer19947336997018299092
   PubMed Web of Science ®Google Scholar
• VernieriCNichettiFRaimondiADiet and supplements in cancer prevention and treatment: Clinical evidences and future perspectivesCrit Rev Oncol Hematol2018123577329482780
   PubMed Web of Science ®Google Scholar